The Use of Bruton Tyrosine Kinase Inhibitors in Waldenstrom's Macroglobulinemia

Khan, AM

Khan, AM (通讯作者),Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.

JOURNAL OF PERSONALIZED MEDICINE, 2022; 12 (5):

Abstract

Waldenstrom's macroglobulinemia (WM) remains an incurable malignancy. However, a number of treatment options exist for patients with WM, including alk......

Full Text Link